{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:47:50Z","timestamp":1767840470802,"version":"3.49.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NeuroRX"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.nurx.2006.01.008","type":"journal-article","created":{"date-parts":[[2006,3,24]],"date-time":"2006-03-24T12:40:16Z","timestamp":1143204016000},"page":"217-224","source":"Crossref","is-referenced-by-count":28,"title":["Therapeutic interventions for tone abnormalities in cerebral palsy"],"prefix":"10.1007","volume":"3","author":[{"given":"Ann H.","family":"Tilton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"30200217_CR1","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1017\/S0012162200001511","volume":"42","author":"Surveillance of Cerebral Palsy in Europe (SCPE)","year":"2000","unstructured":"Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Surveillance of Cerebral Palsy in Europe (SCPE).Dev Med Child Neurol 42: 816\u2013824, 2000.","journal-title":"Dev Med Child Neurol"},{"key":"30200217_CR2","doi-asserted-by":"crossref","first-page":"F169","DOI":"10.1136\/fn.75.3.F169","volume":"75","author":"PO Pharoah","year":"1996","unstructured":"Pharoah PO, Platt MJ, Cooke T. The changing epidemiology of cerebral palsy.Arch Dis Child Fetal Neonatal Ed 75: F169-F173, 1996.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"30200217_CR3","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1017\/S001216220500112X","volume":"47","author":"M Bax","year":"2005","unstructured":"Bax M, Goldstein M, Rosenbaum P, Leviton A, Paneth N, Dan B, Jacobsson B, Damiano D. Proposed definition and classification of cerebral palsy, April 2005.Dev Med Child Neurol 47: 571\u2013576, 2005.","journal-title":"Dev Med Child Neurol"},{"key":"30200217_CR4","first-page":"421","volume":"19","author":"KB Nelson","year":"1978","unstructured":"Nelson KB, Ellenberg JH. Epidemiology of cerebral palsy.Adv Neurol 19: 421\u2013435, 1978.","journal-title":"Adv Neurol"},{"key":"30200217_CR5","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1542\/peds.111.1.e89","volume":"111","author":"TD Sanger","year":"2003","unstructured":"Sanger TD, Delgado MR, Gaebler-Spira D, Hallett M, Mink JW. Classification and definition of disorders causing hypertonia in childhood.Pediatrics 111: e89-e97, 2003.","journal-title":"Pediatrics"},{"key":"30200217_CR6","first-page":"1","volume-title":"Spasticity: etiology, evaluation, management, and the role of botulinum toxin","author":"NH Mayer","year":"2002","unstructured":"Mayer NH. Clinicophysiologic concepts of spasticity and motor dysfunction in adults with an upper motor neuron lesion. In: Spasticity: etiology, evaluation, management, and the role of botulinum toxin (Mayer NH, Simpson DM, eds), pp 1\u201315. New York: WE MOVE, 2002."},{"key":"30200217_CR7","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1002\/(SICI)1097-4598(1997)6+<181::AID-MUS13>3.0.CO;2-9","volume":"6","author":"BS Russman","year":"1997","unstructured":"Russman BS, Tilton A, Gormley ME Jr. Cerebral palsy: a rational approach to a treatment protocol, and the role of botulinum toxin in treatment.Muscle Nerve Suppl 6: S181-S193, 1997.","journal-title":"Muscle Nerve Suppl"},{"key":"30200217_CR8","first-page":"485","volume-title":"Spasticity: disordered motor control","author":"JW Lance","year":"1980","unstructured":"Lance JW. Symposium synopsis. In: Spasticity: disordered motor control (Feldman RG, Young RR, Koella WP, eds), pp 485\u2013494. Chicago: Yearbook Medical, 1980."},{"key":"30200217_CR9","first-page":"1","volume-title":"Muscle overactivity in the upper motor neuron syndrome: the role of oral medications, a focus on dantrolene sodium","author":"NH Mayer","year":"2004","unstructured":"Mayer NH, Herman RM. Phenomenology of muscle overactivity in the upper motor neuron syndrome. In: Muscle overactivity in the upper motor neuron syndrome: the role of oral medications, a focus on dantrolene sodium (Mayer NH, Pierson SH, eds), pp 1\u201325. New York: WE MOVE, 2004."},{"key":"30200217_CR10","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/ptj\/67.2.206","volume":"67","author":"RW Bohannon","year":"1986","unstructured":"Bohannon RW, Smith MB. Interrater reliablity of a modified Ashworth scale of muscle spasticity.Phys Ther 67: 206\u2013207, 1986.","journal-title":"Phys Ther"},{"key":"30200217_CR11","first-page":"151","volume-title":"The diplegic child evaluation and management","author":"J Reimers","year":"1991","unstructured":"Reimers J. Clinically based decision-making for surgery. In: The diplegic child evaluation and management (Sussman MD, ed), p 151. Rosemont, IL: American Academy of Orthopedic Surgeons, 1991."},{"key":"30200217_CR12","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1089\/107555303771952163","volume":"9","author":"W Benda","year":"2003","unstructured":"Benda W, McGibbon NH, Grant KL. Improvements in muscle symmetry in children with cerebral palsy after equine-assisted therapy (hippotherapy).J Altern Complement Med 9: 817\u2013825, 2003.","journal-title":"J Altern Complement Med"},{"key":"30200217_CR13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1469-8749.2002.tb00830.x","volume":"44","author":"C Dali","year":"2002","unstructured":"Dali C, Hansen FJ, Pedersen SA, Skov L, Hilden J, Bjomskov I, Strandberg C, Jette C, Ulla H, Herbst G, Ulla L. Threshold electrical stimulation (TES) in ambulant children with CP: a randomized double-blind placebo-controlled clinical trial.Dev Med Child Neurol 44: 364\u2013369, 2002.","journal-title":"Dev Med Child Neurol"},{"key":"30200217_CR14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0004-9514(05)70003-9","volume":"51","author":"S Hakkennes","year":"2005","unstructured":"Hakkennes S, Keating JL. Constraint-induced movement therapy following stroke: a systematic review of randomised controlled trials.Aust J Physiother 51: 221\u2013231, 2005.","journal-title":"Aust J Physiother"},{"key":"30200217_CR15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1542\/peds.113.2.305","volume":"113","author":"E Taub","year":"2004","unstructured":"Taub E, Ramey SL, DeLuca S, Echols K. Efficacy of constraint-induced movement therapy for children with cerebral palsy with asymmetric motor impairment.Pediatrics 113: 305\u2013312, 2004.","journal-title":"Pediatrics"},{"key":"30200217_CR16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0003-9993(98)90287-8","volume":"79","author":"DL Damiano","year":"1998","unstructured":"Damiano DL, Abel MF. Functional outcomes of strength training in spastic cerebral palsy.Arch Phys Med Rehabil 79: 119\u2013125, 1998.","journal-title":"Arch Phys Med Rehabil"},{"key":"30200217_CR17","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1469-8749.2003.tb00866.x","volume":"45","author":"KJ Dodd","year":"2003","unstructured":"Dodd KJ, Taylor NF, Graham HK. A randomized clinical trial of strength training in young people with cerebral palsy.Dev Med Child Neurol 45: 652\u2013657, 2003.","journal-title":"Dev Med Child Neurol"},{"key":"30200217_CR18","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1469-8749.2003.tb00867.x","volume":"45","author":"H McBurney","year":"2003","unstructured":"McBurney H, Taylor NF, Dodd KJ, Graham HK. A qualitative analysis of the benefits of strength training for young people with cerebral palsy.Dev Med Child Neurol 45: 658\u2013663, 2003.","journal-title":"Dev Med Child Neurol"},{"key":"30200217_CR19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00002060-199705000-00012","volume":"76","author":"WE Carlson","year":"1997","unstructured":"Carlson WE, Vaughan CL, Damiano DL, Abel MF. Orthotic management of gait in spastic diplegia.Am J Phys Med Rehabil 76: 219\u2013225, 1997.","journal-title":"Am J Phys Med Rehabil"},{"key":"30200217_CR20","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/00004694-199705000-00019","volume":"17","author":"H Wilson","year":"1997","unstructured":"Wilson H, Haideri N, Song K, Telford D. Ankle-foot orthoses for preambulatory children with spastic diplegia.J Pediatr Orthop 17: 370\u2013376, 1997.","journal-title":"J Pediatr Orthop"},{"key":"30200217_CR21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/00004694-199805000-00006","volume":"18","author":"IS Corry","year":"1998","unstructured":"Corry IS, Cosgrove AP, Duffy CM, McNeill S, Taylor TC, Graham HK. Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: a randomised prospective trial.J Pediatr Orthop 18: 304\u2013311, 1998.","journal-title":"J Pediatr Orthop"},{"key":"30200217_CR22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1440-1754.1999.00330.x","volume":"35","author":"PJ Flett","year":"1999","unstructured":"Flett PJ, Stern LM, Waddy H, Connell TM, Seeger JD, Gibson SK. Botulinum toxin A versus fixed cast stretching for dynamic calf tightness in cerebral palsy.J Paediatr Child Health 35: 71\u201377. 1999.","journal-title":"J Paediatr Child Health"},{"key":"30200217_CR23","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1469-8749.2003.tb00885.x","volume":"45","author":"M Bottos","year":"2003","unstructured":"Bottos M, Benedetti MG, Salucci P, Gasparroni V, Giannini S. Botulinum toxin with and without casting in ambulant children with spastic diplegia: a clinical and functional assessment.Dev Med Child Neurol 45: 758\u2013762, 2003.","journal-title":"Dev Med Child Neurol"},{"key":"30200217_CR24","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.2106\/00004623-200411000-00003","volume":"86A","author":"RM Kay","year":"2004","unstructured":"Kay RM, Rethlefsen SA, Fem-Buneo A, Wren TA, Skaggs DL. Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy.J Bone Joint Surg Am 86A: 2377\u20132384, 2004.","journal-title":"J Bone Joint Surg Am"},{"key":"30200217_CR25","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1469-8749.2005.tb01215.x","volume":"47","author":"JD Ackman","year":"2005","unstructured":"Ackman JD, Russman BS, Thomas SS, Buckon CE, Sussman MD, Masso P, et al. Comparing botulinum toxin A with casting for treatment of dynamic equinus in children with cerebral palsy.Dev Med Child Neurol 47: 620\u2013627, 2005.","journal-title":"Dev Med Child Neurol"},{"key":"30200217_CR26","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1002\/(SICI)1097-4598(1997)6+<92::AID-MUS7>3.0.CO;2-E","volume":"6","author":"JM Gracies","year":"1997","unstructured":"Gracies JM, Nance P, Elovic E, McGuire J, Simpson DM. Traditional pharmacological treatments for spasticity. Part II: General and regional treatments.Muscle Nerve Suppl 6: S92-S120, 1997.","journal-title":"Muscle Nerve Suppl"},{"key":"30200217_CR27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/tropej\/fmh095","volume":"51","author":"A Mathew","year":"2005","unstructured":"Mathew A, Mathew MC, Thomas M, Antonisamy B. The efficacy of diazepam in enhancing motor function in children with spastic cerebral palsy.J Trop Pediatr 51: 109\u2013113, 2005.","journal-title":"J Trop Pediatr"},{"key":"30200217_CR28","unstructured":"Holt KS. The use of diazepam in childhood cerebral palsy: report of a small study including electromyographic observations.Ann Phys Med [Suppl]:16-24, 1964."},{"key":"30200217_CR29","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1469-8749.1966.tb01824.x","volume":"8","author":"HA Engle","year":"1966","unstructured":"Engle HA. The effect of diazepam (Valium) in children with cerebral palsy: a double-blind study.Dev Med Child Neurol 8: 661\u2013667, 1966.","journal-title":"Dev Med Child Neurol"},{"key":"30200217_CR30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0022-510X(93)90154-Q","volume":"117","author":"M Dahlin","year":"1993","unstructured":"Dahlin M, Knutsson E, Nergardh A. Treatment of spasticity in children with low dose benzodiazepine.J Neurol Sci 117: 54\u201360. 1993.","journal-title":"J Neurol Sci"},{"key":"30200217_CR31","first-page":"398","volume":"5","author":"PJ Milla","year":"1977","unstructured":"Milla PJ, Jackson AD. A controlled trial of baclofen in children with cerebral palsy.J Int Med Res 5: 398\u2013404, 1977.","journal-title":"J Int Med Res"},{"key":"30200217_CR32","first-page":"30","volume":"99","author":"IL Brin","year":"1999","unstructured":"Brin IL, Kurenkov AL, Gotlib VI. [The use of sirdalud in cerebral palsy in children].Zh Nevrol Psikhiatr Im S S Korsakova 99: 30\u201333, 1999.","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"30200217_CR33","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1469-8749.1980.tb03742.x","volume":"22","author":"RL Joynt","year":"1980","unstructured":"Joynt RL, Leonard JA Jr. Dantrolene sodium suspension in treatment of spastic cerebral palsy.Dev Med Child Neurol 22: 755\u2013767, 1980.","journal-title":"Dev Med Child Neurol"},{"key":"30200217_CR34","first-page":"304","volume":"2","author":"AG Nogen","year":"1976","unstructured":"Nogen AG. Medical treatment for spasticity in children with cerebral palsy.Childs Brain 2: 304\u2013308, 1976.","journal-title":"Childs Brain"},{"key":"30200217_CR35","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00007611-197102000-00011","volume":"64","author":"SB Chyatte","year":"1971","unstructured":"Chyatte SB, Birdsong JH, Bergman BA. The effects of dantrolene sodium on spasticity and motor performance in hemiplegia.South Med J 64: 180\u2013185, 1971.","journal-title":"South Med J"},{"key":"30200217_CR36","first-page":"110","volume-title":"Spasticity: etiology, evaluation, management, and the role of botulinum toxin","author":"MF Brin","year":"2002","unstructured":"Brin MF, Aoki KR. Botulinum toxin type A: pharmacology. In: Spasticity: etiology, evaluation, management, and the role of botulinum toxin (Mayer NH, Simpson DM, eds), pp 110\u2013124. New York: WE MOVE, 2002."},{"key":"30200217_CR37","unstructured":"WE MOVE. 2005 Management of spasticity with botulinum toxin type A (BOTOX\u00ae) [Online], 2005. Accessed January 4, 2006."},{"key":"30200217_CR38","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1017\/S0012162205000903","volume":"47","author":"LA Speth","year":"2005","unstructured":"Speth LA, Leffers P, Janssen-Potten YJ, Vles JS. Botulinum toxin A and upper limb functional skills in hemiparetic cerebral palsy: a randomized trial in children receiving intensive therapy.Dev Med Child Neurol 47: 468\u2013473, 2005.","journal-title":"Dev Med Child Neurol"},{"key":"30200217_CR39","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1191\/0269215505cr859oa","volume":"19","author":"D Steenbeek","year":"2005","unstructured":"Steenbeek D, Meester-Delver A, Becher JG, Lankhorst GJ. The effect of botulinum toxin type A treatment of the lower extremity on the level of functional abilities in children with cerebral palsy: evaluation with goal attainment scaling.Clin Rehabil 19: 274\u2013282. 2005.","journal-title":"Clin Rehabil"},{"key":"30200217_CR40","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.apmr.2003.05.008","volume":"85","author":"MA Wallen","year":"2004","unstructured":"Wallen MA, O\u2019Flaherty SJ, Waugh MC. Functional outcomes of intramuscular botulinum toxin type A in the upper limbs of children with cerebral palsy: a phase II trial.Arch Phys Med Rehabil 85: 192\u2013200, 2004.","journal-title":"Arch Phys Med Rehabil"},{"key":"30200217_CR41","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1469-8749.2002.tb00268.x","volume":"44","author":"R Baker","year":"2002","unstructured":"Baker R, Jasinski M, Iag-Tymecka I, Michalowska-Mrozek J, Bonikowski M, Can- L, MacLean J, Lin JP, Lynch B, Theologis T, Wendorff J, Eunson P, Cosgrove A. Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double-blind, placebo-controlled, dose-ranging study.Dev Med Child Neurol 44: 666\u2013675, 2002.","journal-title":"Dev Med Child Neurol"},{"key":"30200217_CR42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1067\/mpd.2000.108393","volume":"137","author":"D Fehlings","year":"2000","unstructured":"Fehlings D, Rang M, Glazier J, Steele C. An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy.J Pediatr 137: 331\u2013337, 2000.","journal-title":"J Pediatr"},{"key":"30200217_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0966-6362(99)00012-0","volume":"10","author":"DH Sutherland","year":"1999","unstructured":"Sutherland DH, Kaufman KR, Wyatt MP, Chambers HG, Mubarak SJ. Double-blind study of botulinum A toxin injections into the gastrocnemius muscle in patients with cerebral palsy.Gait Posture 10: 1\u20139, 1999.","journal-title":"Gait Posture"},{"key":"30200217_CR44","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1469-8749.1997.tb07408.x","volume":"39","author":"IS Cony","year":"1997","unstructured":"Cony IS, Cosgrove AP, Walsh EG, McClean D, Graham HK. Botulinum toxin A in the hemiplegic upper limb: a double-blind trial.Dev Med Child Neurol 39: 185\u2013193, 1997.","journal-title":"Dev Med Child Neurol"},{"key":"30200217_CR45","first-page":"44","volume-title":"Spasticity: etiology, evaluation, management, and the role of botulinum toxin","author":"JM Gracies","year":"2005","unstructured":"Gracies JM, Elovic E, McGuire J, Simpson DM. Traditional pharmacologic treatments for spasticity. Part I: local treatments. In: Spasticity: etiology, evaluation, management, and the role of botulinum toxin (Mayer NH, Simpson DM, eds), pp 44\u201364. New York: WE MOVE, 2005."},{"key":"30200217_CR46","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/01.PHM.0000118038.02326.CA","volume":"83","author":"AM Wong","year":"2004","unstructured":"Wong AM, Chen CL, Chen CP, Chou SW, Chung CY, Chen MJ. Clinical effects of botulinum toxin A and phenol block on gait in children with cerebral palsy.Am J Phys Med Rehabil 83: 284\u2013291, 2004.","journal-title":"Am J Phys Med Rehabil"},{"key":"30200217_CR47","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.apmr.2003.09.032","volume":"85","author":"JL Gooch","year":"2004","unstructured":"Gooch JL, Patton CP. Combining botulinum toxin and phenol to manage spasticity in children.Arch Phys Med Rehabil 85: 1121\u20131124, 2004.","journal-title":"Arch Phys Med Rehabil"},{"key":"30200217_CR48","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1001\/jama.270.20.2475","volume":"270","author":"AL Albright","year":"1993","unstructured":"Albright AL, Barron WB, Fasick MP, Polinko P, Janosky J. Continuous intrathecal baclofen infusion for spasticity of cerebral origin.JAMA 270: 2475\u20132477, 1993.","journal-title":"JAMA"},{"key":"30200217_CR49","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/01376517-200412000-00005","volume":"36","author":"PK Rawlins","year":"2004","unstructured":"Rawlins PK. Intrathecal baclofen therapy over 10 years.J Neurosci Nurs 36: 322\u2013327, 2004.","journal-title":"J Neurosci Nurs"},{"key":"30200217_CR50","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/088307380001500201","volume":"15","author":"R Gilmartin","year":"2000","unstructured":"Gilmartin R, Bruce D, Stons BB, Abbott R, Krach L, Ward J, Bloom K, Brooks WH, Johnson DL, Madsen JR, McLaughlin JF, Nadell J. Intrathecal baclofen for management of spastic cerebral palsy: multicenter trial.J Child Neurol 15: 71\u201377, 2000.","journal-title":"J Child Neurol"},{"key":"30200217_CR51","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00006123-200003000-00017","volume":"46","author":"SP Van","year":"2000","unstructured":"Van SP, Nuttin B, Lagae L, Schrijvers E, Borghgraef C, Feys P. Intrathecal baclofen for intractable cerebral spasticity: a prospective placebo-controlled, double-blind study.Neurosurgery 46: 603\u2013609, 2000.","journal-title":"Neurosurgery"},{"key":"30200217_CR52","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000121223","volume":"27","author":"PC Gerszten","year":"1997","unstructured":"Gerszten PC, Albright AL, Barry MJ. Effect on ambulation of continuous intrathecal baclofen infusion.Pediatr Neurosurg 27: 40\u201344, 1997.","journal-title":"Pediatr Neurosurg"},{"key":"30200217_CR53","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3171\/jns.1998.88.6.1009","volume":"88","author":"PC Gerszten","year":"1998","unstructured":"Gerszten PC, Albright AL, Johnstone GF. Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy.J Neurosurg 88: 1009\u20131013, 1998.","journal-title":"J Neurosurg"},{"key":"30200217_CR54","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1053\/apmr.2002.36068","volume":"83","author":"NA Murphy","year":"2002","unstructured":"Murphy NA, Irwin MC, Hoff C. Intrathecal baclofen therapy in children with cerebral palsy: efficacy and complications.Arch Phys Med Rehabil 83: 1721\u20131725, 2002.","journal-title":"Arch Phys Med Rehabil"},{"key":"30200217_CR55","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/01.pec.0000144919.08619.95","volume":"20","author":"NS Zuckerbraun","year":"2004","unstructured":"Zuckerbraun NS, Ferson SS, Albright AL, Vogeley E. Intrathecal baclofen withdrawal: emergent recognition and management.Pediatr Emerg Care 20: 759\u2013764, 2004.","journal-title":"Pediatr Emerg Care"},{"key":"30200217_CR56","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.pediatrneurol.2005.05.017","volume":"33","author":"FP Darbari","year":"2005","unstructured":"Darbari FP, Melvin JJ, Piatt JH Jr, Adirim TA, Kothare SV. Intrathecal baclofen overdose followed by withdrawal: clinical and EEG features.Pediatr Neurol 33: 373\u2013377, 2005.","journal-title":"Pediatr Neurol"},{"key":"30200217_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/PL00013722","volume":"17","author":"P Steinbok","year":"2001","unstructured":"Steinbok P. Outcomes after selective dorsal rhizotomy for spastic cerebral palsy.Childs Nerv Syst 17: 1\u201318, 2001.","journal-title":"Childs Nerv Syst"},{"key":"30200217_CR58","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00381-004-1105-1","volume":"21","author":"PE Schie van","year":"2005","unstructured":"van Schie PE, Vermeiden RJ, van Ouwerkerk WJ, Kwakkel G, Becher JG. Selective dorsal rhizotomy in cerebral palsy to improve functional abilities: evaluation of criteria for selection.Childs Nerv Syst 21: 451\u2013457, 2005.","journal-title":"Childs Nerv Syst"},{"key":"30200217_CR59","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s007010170016","volume":"143","author":"M Galarza","year":"2001","unstructured":"Galarza M, Fowler EG, Chipps L, Padden TM, Lazareff JA. Functional assessment of children with cerebral palsy following limited (L4-S1) selective posterior rhizotomy-a preliminary report.Acta Neurochir (Wien) 143: 865\u2013872, 2001.","journal-title":"Acta Neurochir (Wien)"},{"key":"30200217_CR60","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1469-8749.1998.tb15456.x","volume":"40","author":"FV Wright","year":"1998","unstructured":"Wright FV, Sheil EM, Drake JM, Wedge JH, Naumann S. Evaluation of selective dorsal rhizotomy for the reduction of spasticity in cerebral palsy: a randomized controlled trial.Dev Med Child Neurol 40: 239\u2013247, 1998.","journal-title":"Dev Med Child Neurol"},{"key":"30200217_CR61","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1469-8749.1997.tb07407.x","volume":"39","author":"P Steinbok","year":"1997","unstructured":"Steinbok P, Reiner AM, Beauchamp R, Armstrong RW, Cochrane DD, Kestle J. A randomized clinical trial to compare selective posterior rhizotomy plus physiotherapy with physiotherapy alone in children with spastic diplegic cerebral palsy.Dev Med Child Neurol 39: 178\u2013184, 1997.","journal-title":"Dev Med Child Neurol"},{"key":"30200217_CR62","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1469-8749.1998.tb15454.x","volume":"40","author":"JF McLaughlin","year":"1998","unstructured":"McLaughlin JF, Bjomson KF, Astley SJ, Graubert C, Hays RM, Roberts TS, Price R, Temkin N. Selective dorsal rhizotomy: efficacy and safety in an investigator-masked randomized clinical trial.Dev Med Child Neurol 40: 220\u2013232, 1998.","journal-title":"Dev Med Child Neurol"},{"key":"30200217_CR63","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3171\/jns.1999.91.5.0727","volume":"91","author":"JR Engsberg","year":"1999","unstructured":"Engsberg JR, Ross SA, Park TS. Changes in ankle spasticity and strength following selective dorsal rhizotomy and physical therapy for spastic cerebral palsy.J Neurosurg 91: 727\u2013732, 1999.","journal-title":"J Neurosurg"},{"key":"30200217_CR64","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/01241398-200409000-00013","volume":"24","author":"MB Johnson","year":"2004","unstructured":"Johnson MB, Goldstein L, Thomas SS, Piatt J, Aiona M, Sussman M. Spinal deformity after selective dorsal rhizotomy in ambulatory patients with cerebral palsy.J Pediatr Orthop 24: 529\u2013536, 2004.","journal-title":"J Pediatr Orthop"},{"key":"30200217_CR65","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3171\/jns.2005.102.2.0363","volume":"102","author":"P Steinbok","year":"2005","unstructured":"Steinbok P, Hicdonmez T, Sawatzky B, Beauchamp R, Wickenheiser D. Spinal deformities after selective dorsal rhizotomy for spastic cerebral palsy.J Neurosurg 102: 363\u2013373, 2005.","journal-title":"J Neurosurg"},{"key":"30200217_CR66","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3171\/jns.1997.86.1.0034","volume":"86","author":"MR Chicoine","year":"1997","unstructured":"Chicoine MR, Park TS, Kaufman BA. Selective dorsal rhizotomy and rates of orthopedic surgery in children with spastic cerebral palsy.J Neurosurg 86: 34\u201339, 1997.","journal-title":"J Neurosurg"},{"key":"30200217_CR67","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/01202412-200507000-00007","volume":"14","author":"G Hagglund","year":"2005","unstructured":"Hagglund G, Andersson S, Duppe H, Pedertsen HL, Nordmark E, Westbom L. Prevention of severe contractures might replace multilevel surgery in cerebral palsy: results of a population-based health care programme and new techniques to reduce spasticity.J Pediatr Orthop B 14: 269\u2013273, 2005.","journal-title":"J Pediatr Orthop B"}],"container-title":["NeuroRX"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1016\/j.nurx.2006.01.008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T12:54:38Z","timestamp":1706964878000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1016\/j.nurx.2006.01.008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["30200217"],"URL":"https:\/\/doi.org\/10.1016\/j.nurx.2006.01.008","relation":{},"ISSN":["1545-5343"],"issn-type":[{"value":"1545-5343","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}